Acadia Pharmaceuticals | Eiendeler



Assets Endring Dato
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
ALKERMES USD 2.08B 26.41M 2025-03
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Biogen USD 28.03B 16.2M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Corcept Therapeutics USD 840.55M 56.3M 2024-12
Cytokinetics USD 1.4B 34.39M 2024-12
Eisai JPY 1.43T 111.45B 2024-12
Eli Lilly USD 89.39B 10.67B 2025-03
Incyte USD 5.75B 305.04M 2025-03
J&J USD 193.67B 13.57B 2025-03
Moderna USD 12.7B 1.44B 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Prothena USD 547.11M 48.15M 2024-12
PTC Therapeutics USD 1.71B 137.21M 2024-12
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
Ultragenyx Pharmaceutical USD 1.5B 34.91M 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Acadia Pharmaceuticals Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.